References
- Lerman A, Gibbons RJ, Rodeheffer RJ, Bailey KR, McKinley LJ, Heublein DM, et al. Circulating N-terminal atrial natriuretic peptide as a marker for symptomless left-ventricular dysfunction. Lancet 1993;341:1105-9. https://doi.org/10.1016/0140-6736(93)93125-K
- McDonagh TA, Robb SD, Murdoch DR, Morton JJ, Ford I, Morrison CE, et al. Biochemical detection of left-ventricular systolic dysfunction. Lancet 1998;351:9-13. https://doi.org/10.1016/S0140-6736(97)03034-1
- Groenning BA, Nilsson JC, Sondergaard L, Kjaer A, Larsson HB, Hildebrandt PR. Evaluation of impaired left ventricular ejection fraction and increased dimensions by multiple neurohumoral plasma concentrations. Eur J Heart Fail 2001;3:699-708. https://doi.org/10.1016/S1388-9842(01)00181-7
- Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, et al. Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. N Engl J Med 2002;347:161-7. https://doi.org/10.1056/NEJMoa020233
- Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, et al. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med 2004;350:647-54. https://doi.org/10.1056/NEJMoa031681
- Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC. Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 1990;12:1179-86 https://doi.org/10.1002/hep.1840120517
- Clyne B, Olshaker JS. The C-reactive protein. J Emerg Med 1999;17:1019-25. https://doi.org/10.1016/S0736-4679(99)00135-3
- Almirall J, Bolibar I, Toran P, Pera G, Boquet X, Balanzo X, et al. Contribution of C-reactive protein to the diagnosis and assessment of severity of community- acquired pneumonia. Chest 2004;125:1335-42. https://doi.org/10.1378/chest.125.4.1335
- Stolz D, Stulz A, Muller B, Gratwohl A, Tamm M. BAL neutrophils, serum procalcitonin, and C-reactive protein to predict bacterial infection in the immunocompromised host. Chest 2007;132:504-14. https://doi.org/10.1378/chest.07-0175
- Castro-Guardiola A, Armengou-Arxe A, Viejo-Rodriguez A, Penarroja-Matutano G, Garcia-Bragado F. Differential diagnosis between community-acquired pneumonia and non-pneumonia diseases of the chest in the emer gency ward. Eur J Intern Med 2000;11:334-9. https://doi.org/10.1016/S0953-6205(00)00118-7
- Sato Y, Takatsu Y, Kataoka K, Yamada T, Taniguchi R, Sasayama S, et al. Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clin Cardiol 1999;22:811-3. https://doi.org/10.1002/clc.4960221211
- Mueller C, Laule-Kilian K, Christ A, Brunner-La Rocca HP, Perruchoud AP. Inflammation and long-term mortality in acute congestive heart failure. Am Heart J 2006; 151:845-50. https://doi.org/10.1016/j.ahj.2005.06.046
- Windram JD, Loh PH, Rigby AS, Hanning I, Clark AL, Cleland JG. Relationship of high-sensitivity C-reactive protein to prognosis and other prognostic markers in outpatients with heart failure. Am Heart J 2007;153: 1048-55. https://doi.org/10.1016/j.ahj.2007.03.044
- Milo O, Cotter G, Kaluski E, Brill A, Blatt A, Krakover R, et al. Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes. Am J Cardiol 2003;92:222-6.
- Swedberg K, Cleland J, Dargie H, Drexler H, Follath F, Komajda M, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 2005;26:1115-40. https://doi.org/10.1093/eurheartj/ehi204
- Maeder MT, Kaye DM. Heart failure with normal left ventricular ejection fraction. J Am Coll Cardiol 2009;53: 905-18. https://doi.org/10.1016/j.jacc.2008.12.007
- Campbell GD. Overview of community-acquired pneumonia: prognosis and clinical features. Med Clin North Am 1994;78:1035-48. https://doi.org/10.1016/S0025-7125(16)30118-3
- Tripathi M, Pandey M, Nepal B, Rai H, Bhattarai B. Evaluation of lung infiltration score to predict postural hypoxemia in ventilated acute respiratory distress syndrome patients and the lateralization of skin pressure sore. Indian J Med Sci 2009;63:392-401. https://doi.org/10.4103/0019-5359.56110
- Cowie MR, Struthers AD, Wood DA, Coats AJ, Thompson SG, Poole-Wilson PA, et al. Value of natriuretic peptides in assessment of patients with possible new heart failure in primary care. Lancet 1997;350:1349-53. https://doi.org/10.1016/S0140-6736(97)06031-5
- Davis M, Espiner E, Richards G, Billings J, Town I, Neill A, et al. Plasma brain natriuretic peptide in assessment of acute dyspnoea. Lancet 1994;343:440-4. https://doi.org/10.1016/S0140-6736(94)92690-5
- Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, et al. Diastolic dysfunction and natriuretic peptides in systolic heart failure: higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996;17:1694-702. https://doi.org/10.1093/oxfordjournals.eurheartj.a014753
- Maeda K, Tsutamoto T, Wada A, Hisanaga T, Kinoshita M. Plasma brain natriuretic peptide as a biochemical marker of high left ventricular end-diastolic pressure in patients with symptomatic left ventricular dysfunction. Am Heart J 1998;135(5 Pt 1):825-32. https://doi.org/10.1016/S0002-8703(98)70041-9
- Joffe E, Justo D, Mashav N, Swartzon M, Gur H, Berliner S, et al. C-reactive protein to distinguish pneumonia from acute decompensated heart failure. Clin Biochem 2009;42:1628-34. https://doi.org/10.1016/j.clinbiochem.2009.08.007
Cited by
- C-reactive protein evaluation in communityacquired pneumonia with comorbid chronic heart failure as criterion of antibiotic prescription vol.59, pp.2, 2013, https://doi.org/10.18087/cardio.2661
- Community-acquired pneumonia in patients with chronic heart failure: clinical manifestation and a diagnostic role of biomarkers vol.29, pp.4, 2013, https://doi.org/10.18093/0869-0189-2019-29-4-391-402
- Biomarker Value in the Diagnosis of Community-Acquired Pneumonia with Concomitant Chronic Heart Failure vol.10, pp.19, 2021, https://doi.org/10.3390/jcm10194570
- Implications of cardiac markers in risk-stratification and management for COVID-19 patients vol.25, pp.None, 2013, https://doi.org/10.1186/s13054-021-03555-z